Trending Now
Business
Endo Just Shot The Lights Out
Endo International (ENDP) reported Q4 2018 revenue of $786.39 million and non-GAAP eps of $0.75. The company beat on revenue by $47.87 million. It...
Mavyret Could Amplify Gilead’s HCV Pain
An HCV price war between Gilead (GILD) and AbbVie (ABBV) could heat up. AbbVie recently received FDA approval for Mavyret, its new HCV drug....
Lifestyle today
Entertainment
BlackRock’s Larry Fink Makes Colossal Bet On Endo
Endo Pharmaceuticals' (ENDP) fortunes appear to have taken a turn for the better. In May I suggested that exciting drugs in its pipeline could...
Endo: Takeda Deal For Generic Colcrys Is Bullish For 2 Reasons
Things are starting to look up for Endo International (ENDP). Last month Citigroup (C) upgraded the company to "buy" and highlighted Endo's "next big...
Did Nevada Lose $240 Million By Refusing Global Opioid Deal?
Former president Donald Trump was highly critical of opioid drug manufacturers. He wanted to shed more light on their role in the...
Allergan: Restasis Lawsuit From Kroger, Walgreen Could Cost Billions
Allergan (AGN) has gone to lengths to protect its patents. Drug makers have every right to protect their intellectual property. They practically have a...
Are Valeant, Ackman The ‘Edgar Allan Poe Of Insider Trading’?
"The Purloined Letter" is one of Edgar Allen Poe's most famous crime stories. A woman had her letter stolen by an unnamed minister. It...
$400 Million Exposure To Venezuela Could Haunt Halliburton
Venezuela is beset by recession, crime and stagflation. President Nicolas Maduro has cracked down on state-run oil company PDVSA; he has arrested the former...
Plagiarism Concerns Swirl Around Harvard President
The past week has been a whirlwind of news, particularly at Ivy League schools such as the University of Pennsylvania, Harvard, and...
Letitia James Claps Back At Trump And The GE And ‘Anarchy’ Claim
New York State Attorney General Letitia James is arguably one of the most active attorney generals in New York history. She has actively sought...























































































































